Healthy
Conditions
Keywords
modafinil, emotion, cognitive processing
Brief summary
The study aims to examine whether a single dose of modafinil (200mg, p.o.) can affect feedback-based learning and interference processing in healthy male subjects.
Detailed description
Based on previous animal and human research suggesting a catecholamine-mediated, potentially pro-cognitive, mechanism of action of modafinil, the present study seeks to explore effects of modafinil on feedback-based learning and interference processing in healthy subjects. To this end, the present randomized double-blind, between-subject, placebo-controlled pharmaco-fMRI experiment plans to determine the behavioral and neural effects of a single dose of p.o.modafinil (200mg) versus placebo on validated feedback-based learning and emotional/non-emotional cognitive conflict paradigms. To control for potential effects of pre-medication personality traits as well as effects of modafinil on subjective task performance, subjects will be administered pre-treatment assessing relevant personality traits and post-treatment assessments of meta-cognitive confidence estimation.
Interventions
modafinil 200mg
placebo 200mg
Sponsors
Study design
Eligibility
Inclusion criteria
* Healthy subjects without past or current psychiatric or neurological disorders * Non-smokers * Right-handedness
Exclusion criteria
* Medical or psychiatric illness * Allergy against medications or general strong allergies * Sleep disorders * High blood pressure, general cardio-vascular alterations * History of head injury * Visual or motor impairments
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Neural processing during the interference processing | 4h after treatment | fMRI BOLD indices of neural processing in interference related brain regions will be compared between the treatment and placebo group. |
| Neural processing during feedback based learning | 4h after treatment | fMRI BOLD indices of neural processing learning related brain regions will be compared between the treatment and placebo group. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Behavioral interference performance - Response Time | 4h after treatment | Behavioral performance of interference performance for congruent and incongruent stimuli (picture vs word) will be compared between the treatment and placebo group. |
| Behavioral interference performance - Accuracy | 4h after treatment | Behavioral performance of interference in terms of accuracy for congruent and incongruent trials (picture vs word) will be compared between the treatment and placebo group. |
| Behavioral learning performance - Reaction time | 4h after treatment | Learning performance in terms of reaction times will be compared between the treatment and placebo group. |
| Behavioral learning performance - Accuracy | 4h after treatment | Learning performance in terms of accuracy (learning curve, trials to reach plateau) will be compared between the treatment and placebo group. |
Countries
China